6,423 press releases indexed under healthcare.
The multi-author book was funded by Ansys — part of Synopsys — and Johnson & Johnson. The authors will present key applications during a webinar on September 10. ROCHESTER, N.Y., Aug. 26, 2026 /PRNewswire/ -- SimuTech Group announces the publication of a new chapter co-authored by two of...
New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing...
The oncolytic virus cancer therapy market is poised for significant growth, driven by increasing research and development of genetically engineered viruses that selectively target and destroy cancer cells while stimulating anti-tumor immune responses. The expanding clinical pipeline of...
LONDON, August 26, 2026--Flo Health, the #1 female health app used by more than 300 million people worldwide, has completed its annual ISO 27001 and ISO 27701 audits, which returned zero findings. This means independent auditors identified no areas for improvement in the company's privacy and security management systems.
LONDON, August 26, 2026--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced that the U.S. Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir (DTG)), for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in paediatric patients (treatment-naïve or -experienced but integrase strand transfer inhibitor (INSTI)-naïve) weighing at least 2 kg.
Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation is focused on whether the Company improperly shared private user health data with advertisers, engaged in deceptive billing practices, and made...
The immune system is full of T cells that could hunt down and destroy tumors, if they were primed. Now, a UC San Francisco team has invented a way to do this by combining immune cells that are grown in the lab with samples from a patient's tumor. - - Like giving a scent to a hound dog, it provides direction to the immune system on how to track down the cancer. - - To catch the scent, the T cells need to be trained using rare dendritic immune cells that are hard to obtain from cancer patients... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359535
Partnership brings Monod Bio’s LuxSit luciferase and NovoBodies to SignalChem Biotech’s custom assay services Agreement expands Sino Biological’s specialized CRO capabilities through integration of AI-enabled life science tools SEATTLE and RICHMOND, BRITISH COLUMBIA - August 26, 2026 ( NEWMEDIAWIRE ) - Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. (SZSE: 301047), today announced a non-exclusive licensing agreement covering Monod Bio’s proprietary LuxSit de novo luciferase technology and NovoBodies. Under the terms of the agreement, SignalChem Biotech may incorporate the Monod Bio technologies into custom luminescent assay development and protein-fusion services offered to third-party customers f
NeOnc’s (NASDAQ: NTHI) Clinical Story Is Now the Main Event
DALLAS - August 26, 2026 ( NEWMEDIAWIRE ) - Sudden cardiac arrest is the leading cause of death for student-athletes nationwide, with nearly 75% of cases among young athletes occurring in basketball, football and soccer players. [1] To help youth sports coaches and league leaders prepare for these emergencies, the American Heart Association, devoted to changing the future to a world of healthier lives for all, is hosting a free one-hour webinar focused on Cardiac Emergency Response Plans and safe play practices. The webinar, taking place Wednesday, Sept. 30, at 1 p.m. CT, reflects the American Heart Association's ongoing commitment to improving cardiac emergency preparedness and advances the goals of its Nation of Lifesavers™ movement, which aims to double survival rates from cardiac arres
WOBURN, Mass., Aug. 26, 2026 /PRNewswire/ -- Cytrellis Biosystems, Inc. ("Cytrellis") a medical aesthetics company bridging the gap in skin health and restoration, today announced the commercial launch of ellacor® with Micro-Coring Technology in Australia following regulatory approval...
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21 st Annual Healthcare Conference on Wednesday, September 9, 2026.